← Back to patent-cliff list
青蒿琥酯/磷酸咯萘啶
Tier C — Watch / tradeArtesunate/Pyronaridine Phosphate
韩国新丰制药株式会社
Originator
2012
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ATP2A2、ATP2A1
Brand：Pyramax
Indications (approved)：疟原虫感染
Regional status
US
-
EU
临床三期
2021-10-18
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Artesunate/Pyronaridine Phosphate?
Approved indications include: 疟原虫感染.
When does the Artesunate/Pyronaridine Phosphate patent expire?
No public expiry year is available for Artesunate/Pyronaridine Phosphate yet; this page updates once verified.
How do I get a quote for Artesunate/Pyronaridine Phosphate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24